Target intelligence / Profile preview

Homeodomain-interacting protein kinase 1 (HIPK1)

Target
HIPK1
Molecular classification
Enzyme, Serine/threonine protein kinase, HIPK subfamily
01

Overview

Homeodomain-interacting protein kinase 1 (HIPK1) is a highly conserved enzyme of the serine/threonine kinase family, predominantly localized in the nucleus. It modulates transcription factor activity—particularly homeodomain-containing proteins—by phosphorylation, acting as both a kinase and co-repressor. HIPK1 participates in cellular stress responses, apoptosis, transcriptional regulation, and cell proliferation. Experimental evidence suggests a role in tumorigenesis, eye and erythroid development, and regulation of organ size. The enzyme is closely related to other HIPK family members (HIPK2, HIPK3, HIPK4) and interacts with targets such as TP53/p53. Functional redundancy and overlapping biological roles are documented among HIPK family kinases[1][3][4][5].

Other names
MYAKNBAK2Nuclear body-associated kinase 2
02

Mechanism of action

Kinase inhibitors (general concept, not documented for HIPK1-specific drugs); Modulation of transcription factor activity via phosphorylation; Regulation of apoptosis signaling pathways

03

Biological functions

Phosphorylation of transcription factors (including homeodomain proteins)Transcriptional regulation and co-repressionApoptosis, especially TNF-mediated apoptosisCell cycle regulationCell proliferation and survivalRegulation of oxidative stress responses
04

Disease associations

Cancer (malignant squamous cell tumor formation)Neurodegenerative disease (in model organisms, HIPK family maintains neuronal integrity and proteostasis)Other (eye development, erythroid differentiation, angiogenesis)
05

Safety considerations

Therapeutic inhibition may impact apoptosis and cell cycle regulation, potentially affecting normal tissue homeostasis and increasing risk of off-target toxicity

Beyond the preview

Go deeper on Homeodomain-interacting protein kinase 1 (HIPK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homeodomain-interacting protein kinase 1 (HIPK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call